Android app Apple app link

J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis

By Yahoo! Finance   |   1 month ago
J&J eyes FDA approval for injection-based Tremfya in ulcerative colitis

J&J seeks FDA approval for new SC injection option for Tremfya in UC treatment. Phase III study shows positive results for symptom relief and colon healing. If approved, it would provide patients with a choice between SC and IV induction.

Read More

Did you find this insightful?

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.